Latest Europe News

Credit Clear appoints Joshua Reid as Managing Director and interim CEO of ARMA Group Holdings, signaling a leadership shift aligned with its growth ambitions across Australia and international markets.

European Lithium and Critical Metals Corp have amended their merger terms to replace a fixed share exchange ratio with a floating ratio tied to Critical Metals' NASDAQ share price, potentially increasing shareholder value amid ongoing merger progress.

Schaffer Corporation reported a modest 8.6% decline in net profit for FY26 to $22.2 million, with a rebound in Automotive Leather offset by a loss at Delta and strong gains from its South Connect Jandakot property development.

Entropy Neurodynamics has partnered with BioCina to establish GMP manufacturing for its intravenous psilocin formulation TRP-8803, a critical step toward late-stage clinical trials and commercialisation.

Energy One (ASX:EOL) reported a strong FY26 with 14% revenue growth and 38% profit rise, announcing a transformative $99.8 million all-scrip acquisition of Gas Management Services Limited (GMSL) that will deepen its European footprint and bring Fluxys onboard as a major shareholder.

Victory Metals (ASX: VTM) has delivered a robust Pre-Feasibility Study for its North Stanmore rare earth project, confirming a 47 Mt Probable Ore Reserve and strong economics underpinned by low capital intensity and a high-grade mineral resource.

Pro Medicus delivered a robust FY26 with 28% underlying revenue growth, a surge in new contract wins worth $407 million, and a 25% increase in fully franked dividends, underpinned by strong AI product development and rapid implementations.

EML Payments reported a 6% revenue decline and an 18% drop in underlying EBITDA for FY26, completing a major restructuring and advancing its Arlo technology platform. The company projects FY27 EBITDA between $50 million and $54 million, with a strong new program pipeline and strategic investments underpinning growth.

Yugo Metals continues to hit significant gold grades in its maiden drilling at the Erak Prospect, with mineralisation open in multiple directions and further drilling underway.

CSL Limited’s FY2026 results reveal modest revenue growth offset by a multibillion-dollar statutory loss driven by restructuring and impairments, alongside a maintained dividend and a strategic focus on sustainable growth.

Scott Technology has locked in NZ$20 million worth of new Materials Handling & Logistics contracts across North America and Europe, reinforcing its Destination 2030 growth strategy and building on strong FY26 momentum.

Mesoblast has treated 350 patients in its pivotal Phase 3 trial for rexlemestrocel-L, targeting chronic low back pain linked to degenerative disc disease, setting the stage for top-line results in mid-2027.